Frequency and risk factors of infectious complications in neutropenic patients infected with HIV

AIDS

Volumn 11, Issue 8, 1997, Pages 995-998

  Meynard, Jean Luc ^a,b   Guiguet, Marguerite ^a   Arsac, Stéphanie ^a   Frottier, Jacques ^a   Meyohas, Marie Caroline ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

AIDS; Bacterial infections; Neutropenia

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; GANCICLOVIR; SULFADIAZINE; SULFAMETHOXAZOLE; TRIMETHOPRIM; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; FEMALE; FRANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS COMPLICATION; LEUKOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT INFECTION; RISK FACTOR; STATISTICAL MODEL; TEACHING HOSPITAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; NEUTROPENIA; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0030998330     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199708000-00007     Document Type: Article

References (16)

1. Abrams DI, Chinn EK, Lewis BJ, et al.: Hematologic manifestations in homosexual men with Kaposi's sarcoma. Am J Clin Pathol 1984, 81:13-18.
2. Zon LI, Arkin C., Groopman JE: Haematologic manifestations of the human immune deficiency virus. Br J Haematol 1987, 66:251-256.
3. Castella A, Cloxson TS, Mildvan D, et al.: The bone marrow in AIDS. Am J Clin Pathol 1984, 84:425-432.
4. Groopman JE: Management of the hematologic complications of human immunodeficiency virus infection. Rev Infect Dis 1990, 12:931-937.
5. Perkocha LA, Rodgers GM: Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical consideration. Am J Hematol 1988, 29:94-105.
6. Murphy MF, Metcalfe P, Waters AH, et al.: Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 1987, 66:337-340.
7. Clement M: General approach to the human immunodeficiency virus-infected patient. In Opportunistic Infections in Patients with the Acquired Immunodeficiency Syndrome. Edited by Leoung G, Mills G. New York: Marcel Dekker; 1989:88-101.
8. Farber BF, Lesser M, Kaplan MH, et al.: Clinical significance of neutropenia in patients with human immunodeficiency virus infection Infect Control Hosp Epidemiol 1991, 12:429-434.
9. Hambleton J, Aragon T,. Modin G, et al.: Outcome for hospitalized patients with fever and neutropenia who are infected with the human immunodeficiency virus. Clin Infect Dis 1995, 20:363-371.
10. Folks TM: Human immunodeficiency virus in bone marrow: still more questions than answers. Blood 1991, 77:1625-1626.
11. Zon LI, Groopman JE: Hematologic manifestations of the human immune deficiency virus (HIV). Semin Hematol 1988, 25:208-218.
12. Shaunak S, Bartlett JA: Zidovudine-induced neutropenia: are we too cautious? Lancet 1989, ii:91-92
13. Hughes WT, Armstrong D, Bodey GP, et al.: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990, 161:381-396.
14. Hermans P, Sommereijns B, Vancutsem N, Clumeck N: Neutropenia in HIV-positive patients: a case control study in a cohort of 1403 patients between 1982 and 1993. XXXV Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, September 1995 [abstract 1248].
15. Scaden DT: The use of GM-CSF in AIDS. J Infection 1992, 20:103-106.
16. Hermans P: Haematopoietic growth factors as supportive therapy in HIV-infected patients. AIDS 1995, 9 (Suppl 2):S9-S14.